Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients

August 12, 2013 updated by: National Taiwan University Hospital

Cancer is one of the leading health issues in this country and worldwide. Angiogenesis is an essential process for tumoral growth and metastasis. This process is dependent on the balance between angiogenic factors and antiangiogenic factors. Muscle wasting has been associated with myostatin overexpression in cancer. Exercise training can depress tumor growth and suppress myostatin expression, and enhance skeletal muscle angiogenesis in healthy people and some animal studies. The purpose of this study is mainly to investigate the effects of exercise training on

  1. circulating VEGF-A
  2. muscle growth and function
  3. Myostatin

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei City, Taiwan, 100
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 40-75 years
  • Advanced NSCLC
  • Eastern Cooperative Oncology Group performance status of 0 or 1
  • Targeted therapy for at least 8 weeks
  • Stable condition

Exclusion Criteria:

  • Severe metastasis, cardiopulmonary or musculoskeletal conditions may affect participation in exercise
  • Do not understand the verbal or written instructions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise training
Subjects in exercise group will undergo individualized high aerobic interval training on treadmill for 30 minutes under the supervision of an experienced physical therapist 3 times a week and home exercise twice a week with accelerometer.
Subjects in exercise group will undergo individualized high aerobic interval training on treadmill for 30 minutes under the supervision of an experienced physical therapist 3 times a week and home exercise twice a week with accelerometer.
Other Names:
  • High intensity interval aerobic training
Active Comparator: Control group
Subjects in control group will not undergo individualized high aerobic interval training on treadmill. They will receive usual care as normally does in hospital.
Subjects in control group will not undergo individualized high aerobic interval training on treadmill. They will receive usual care as normally does in hospital.
Other Names:
  • Non-exercise or patient education

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise capacity
Time Frame: 8 weeks after the start of the intervention
Maximal oxygen consumption with Vmax229 Vastus lateral muscle oxygenation with NIRS
8 weeks after the start of the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Imaging of muscle
Time Frame: 8 weeks and 16 weeks after the start of the intervention
Measured by MRS
8 weeks and 16 weeks after the start of the intervention
Analysis of venous blood sample
Time Frame: 8 weeks andd 16 weeks after the start of the intervention
Analysis of circulating VEGF-A and myostatin
8 weeks andd 16 weeks after the start of the intervention
Quality of life
Time Frame: baseline, 8 weeks, 16 weeks
Measured by questionnaire
baseline, 8 weeks, 16 weeks
Exercise capacity
Time Frame: 16 weeks after the start of the intervention
Maximal oxygen consumption with Vmax229 Vastus lateral muscle oxygenation with NIRS
16 weeks after the start of the intervention
Muscle function
Time Frame: 8 weeks and 16 weeks after the start of the intervention
Isokinetic muscle strength and endurance with Biodex
8 weeks and 16 weeks after the start of the intervention
Physical activity
Time Frame: 8 weeks andd 16 weeks after the start of the intervention
Measured with 7-day recall questionnaire
8 weeks andd 16 weeks after the start of the intervention
Dietary intake
Time Frame: 8 weeks andd 16 weeks after the start of the intervention
Measured with 24-hour recall questionnaire
8 weeks andd 16 weeks after the start of the intervention
Body composition
Time Frame: 8 weeks andd 16 weeks after the start of the intervention

Body mass index calculated with body weight and height

% body fat abd free-fat mass with BIA

8 weeks andd 16 weeks after the start of the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

August 1, 2011

Study Completion (Actual)

August 1, 2012

Study Registration Dates

First Submitted

May 10, 2010

First Submitted That Met QC Criteria

June 2, 2010

First Posted (Estimate)

June 3, 2010

Study Record Updates

Last Update Posted (Estimate)

August 13, 2013

Last Update Submitted That Met QC Criteria

August 12, 2013

Last Verified

November 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Non-small-cell Lung Cancer

Clinical Trials on Exercise training

Subscribe